ABLE-32: A randomized, controlled, phase 3b clinical trial of nadofaragene firadenovec-vncg versus observation in patients with intermediate-risk non–muscle-invasive bladder cancer. This is an ASCO ...
Announcing a new publication for Acta Materia Medica journal. Fatty acid (FA) reprogramming has a significant role in liver cancer. However, the contribution of FA metabolism reprogramming to the ...
Medium- and short-chain fatty acids (C8-C14) are widely used in industries including food, pharmaceuticals, lubricants, and surfactants, and they are currently mainly extracted from coconut and palm ...
This study is led by Prof. Dr. Shengying Li (State Key Laboratory of Microbial Technology, Shandong University) and Ass. Prof. Dr. Biaobiao Zhang (School of Science, Westlake University). The team ...
The monoclonal antibody Herceptin drastically improves prognosis for patients with HER2+ breast cancer. But if the primary tumor metastasizes to the brain, it often fails to respond to treatments.
Pairing antibiotics with drugs that prevent bacteria from producing fatty acids may help combat antibiotic resistance. The drug combination was more effective at treating bacterial pneumonia in mice ...
Objective Macrophages and kidney cell pyroptosis/ferroptosis could play an important role in the pathogenesis of lupus ...
This review explains how glucose scarcity, lipid disruption, amino acid deprivation, and toxic metabolites weaken CAR-T cells ...
Short-chain fatty acids (SCFAs) are an important class of biologically active substances produced in the gut, specifically by the action of gut bacteria on plant-derived foods containing fiber that is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results